Interim report January - June 2009

Interim report January - June 2009

Second quarter 2009
- The Group reported an operating loss of SEK 24 m (loss: 8)
- After taxes, the Group's loss was SEK 18 m (loss: 3)
- Loss per share amounted to SEK 0.27 (loss: 0.03)
- Cash flow during the period was a negative SEK 28 m (negative: 22)
- The portfolio company CMA Microdialysis acquired the outstanding shares in the
associated company Dipylon Medical
- Jointly with Altor Fund III, the portfolio company Bure completed the
acquisition of Carnegie Investment Bank and Max Matthiessen from the Swedish
National Debt Office

Interim report period January - June 2009
- The Group reported an operating loss of SEK 36 m (loss: 3)
- After taxes, the Group's loss was SEK 18 m (profit: 1)
- Loss per share amounted to SEK 0.25 (profit: 0.02)
- Cash flow during the period amounted to SEK 176 m (negative: 79)
- The decline in earnings of the subsidiary MYDATA continued. The operating loss
amounted to SEK 69 m, of which losses on currency forward contracts totaled SEK
35 m
- The portfolio company Bure completed its redemption program. Skanditek
received SEK 201 m

After the end of the interim period
- Skanditek completed the divestment of the subsidiary MYDATA and became the
largest share owner in Micronic Laser Systems, with a 38.0 of the shares


Further information, please contact:
Patrik Tigerschiöld, President
Phone + 46 8 614 00 20
Andreas Berglin, CFO
Phone + 46 8 614 00 20


The information in this interim report is of the type that Skanditek is
obligated to disclose in accordance with the Securities Market Act and the
Financial Instruments Trading Act. The information was submitted for disclosure
on August 31, 2009 at 8.45 a.m. CET.